Cancer Biology and Treatment – from Computational Models to Treatment Decisions
a CONTRA Innovative Training Network Workshop
Cambridge, September 2-6, 2019
This workshop is organized by the CONTRA (Computational ONcology TRaining Alliance) Innovative Training Network, a joint effort of KTH Royal Institute of Technology, Sweden (coordinator), University of Warsaw, Poland, University of Cambridge, UK, King’s College London-Francis Crick Institute, UK, The Institute of Cancer Research, UK, Institute for Research in Biomedicine (IRB), Spain, University of Vigo, Spain, and ETH Zurich, Switzerland.
In the CONTRA Innovative Training Network, we are interested in studying the evolutionary processes of tumors. In this workshop we will focus on “Cancer Biology and Treatment” and we will discuss different ways to translate experimental evidence and computational models into clinical decision making. World leading experts with different viewpoints on cancer genomics and translational medicine will present their work in lectures.
Event Stucture: a Workshop in Two Parts
2 Days of Internal Network Workshop:
– The CONTRA Early Stage Researchers (ESRs) will get hands on practice in biostatistics.
2 Days of Open Workshop (5-6 Sept.): Lectures by Invited Speakers:
– “Cancer Biology and Treatment – from computational models to treatment decisions” Workshop of the ITN-CONTRA (Computational Oncology Training Alliance).
List of Speakers
Co-leader of the Anglia Cancer Network Breast Cancer Chemotherapy Treatment Algorithms and actively involved in leading the design and development of biomarker directed clinical trials, which aims to treat patients in a more targeted fashion.
Senior lecturer at the Centre for Genomic and Experimental Medicine in the University of Edinburgh where he develops new and practical approaches to analyse whole slide scans of tissue, collaborating with pathologists and other researchers to apply these methods to answer important biomedical questions.
Senior group leader of Functional Genomics of Ovarian Cancer laboratory at Cancer Research UK (CR-UK) Cambridge Institute.
Leader of the Pattern Recognition and Digital Medicine group at Hi-STEM (Heidelberg Institute for Stem Cell Technology and Experimental Medicine)
Chief Scientist at AstraZeneca since 2017 with a focus on drug resistance in cancer, after eight years at the Wellcome Sanger Institute (seven of those as group leader).
Group leader at the Theory Division of Cleveland Clinic. He is a radiation oncologist who specializes in the care of patients with Sarcoma and a theoretical oncologist who thinks about the fundamental evolutionary mechanisms driving therapeutic resistance.
Director of the Center of Translational Genomics and Bioinformatics.
Head of the Functional Genomics of Cancer Unit at IRCCS Ospedale San Raffaele.
Leader of the CRUK Accelerator project Single Cell Evolution in the Clinic.
Leader of the TRAcking renal cell Cancer Evolution through Therapy (TRACERx Renal) study at the Francis Crick Institute. Medical oncologist at the Royal Marsden Hospital, specialising in the systemic treatment of renal cell carcinoma and melanoma.
Note: The conference dinner is on the 5th of September.
Registration is now closed.
Florian Markowetz, CONTRA CRUK Cambridge PI
Paula Martin-Gonzalez, CONTRA PhD student
Michael Schneider, CONTRA PhD student
Ewa Szczurek, CONTRA events coordinator
Jens Lagergren, CONTRA coordinator
Iwona Zielińska, project assistant
All the sessions will be held at St Catharine’s College. Accommodation and dinner will also be provided there.
St Catharine’s College
How to get there: https://www.caths.cam.ac.uk/about-us/visiting-college
Meeting room (internal CONTRA ITN conference):
Workshop venue (external workshop):